{"url":"https://lda.senate.gov/api/v1/filings/ac5b29ed-d4ea-4c8f-b6c7-962d99bdf756/","filing_uuid":"ac5b29ed-d4ea-4c8f-b6c7-962d99bdf756","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2021,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/ac5b29ed-d4ea-4c8f-b6c7-962d99bdf756/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Katie Landes","dt_posted":"2022-01-20T14:42:15.937000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Ave NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105372,"url":"https://lda.senate.gov/api/v1/registrants/401105372/","house_registrant_id":null,"name":"THE KPM GROUP DC LLC","description":"lobby firm","address_1":"5331 16th Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20011","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISA HESS","contact_telephone":"+1 434-933-2535","dt_updated":"2026-07-20T15:33:02.088040-04:00"},"client":{"id":203598,"url":"https://lda.senate.gov/api/v1/clients/203598/","client_id":24,"name":"OPIANT PHARMACEUTICALS","general_description":"Pharmaceutical company; develops medicines for the treatment of addictions and overdose","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-09-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Substance Abuse Treatment","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73276,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120191,"prefix":null,"prefix_display":null,"first_name":"JOSEPH","nickname":null,"middle_name":null,"last_name":"BALLARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107218,"prefix":null,"prefix_display":null,"first_name":"JACOB","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}